no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A Case Series of Post-Transplantation Cyclophosphamide in Unrelated Donor Hematopoietic Cell Transplantation for Aplastic Anemia
|
Arcuri, Leonardo Javier |
|
|
26 |
9 |
p. e222-e226 |
article |
2 |
A Novel Strategy for the Prevention of Hepatitis B Virus-Related Hepatitis Following Allogeneic Hematopoietic Stem Cell Transplantation from Hepatitis B Surface Antigen-Positive Donors
|
Wu, Yibo |
|
|
26 |
9 |
p. 1719-1728 |
article |
3 |
A Prospective Survey of Outpatient Medication Adherence in Adult Allogeneic Hematopoietic Stem Cell Transplantation Patients
|
Ice, Lauren L. |
|
|
26 |
9 |
p. 1627-1634 |
article |
4 |
Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies? A Review from the Chronic Malignancies Working Party of the EBMT
|
Garderet, Laurent |
|
|
26 |
9 |
p. 1559-1566 |
article |
5 |
ASTCT Notes
|
|
|
|
26 |
9 |
p. 1757-1758 |
article |
6 |
Caregivers’ Out-of-Pocket Expenses and Time Commitment Following Hematopoietic Stem Cell Transplantation at a Rural Cancer Center
|
Meehan, Kenneth R. |
|
|
26 |
9 |
p. e227-e231 |
article |
7 |
Chains of Iron in Umbilical Cord Blood Hematopoietic Stem Cell Transplantation: Comment on “Iron Overload Is Associated with Delayed Engraftment and Increased Nonrelapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell Transplantation” by Al Malki et al, 2020
|
Knovich, Mary Ann |
|
|
26 |
9 |
p. e213-e214 |
article |
8 |
Chimeric Antigen Receptor T Cell Therapy Delivers Response in Lymphoma Progressing after Allogeneic Transplantation, but is the Sequence Optimal?
|
Locke, Frederick L. |
|
|
26 |
9 |
p. e211-e212 |
article |
9 |
Comparative Study of Mizoribine and Mycophenolate Mofetil Combined with a Calcineurin Inhibitor-Based Immunosuppressive Regimen in Patients with Alternative Donor Hematopoietic Cell Transplantation
|
Huang, Yong |
|
|
26 |
9 |
p. 1663-1669 |
article |
10 |
Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma
|
Oluwole, Olalekan O. |
|
|
26 |
9 |
p. 1581-1588 |
article |
11 |
Editorial Board
|
|
|
|
26 |
9 |
p. A11 |
article |
12 |
Efficacy and Safety of Revaccination against Tetanus, Diphtheria, Haemophilus influenzae Type b and Hepatitis B Virus in a Prospective Cohort of Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
|
Conrad, Anne |
|
|
26 |
9 |
p. 1729-1737 |
article |
13 |
Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
|
Schubert, Maria-Luisa |
|
|
26 |
9 |
p. 1575-1580 |
article |
14 |
Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation
|
Kliman, David |
|
|
26 |
9 |
p. 1711-1718 |
article |
15 |
Human-Derived α1-Antitrypsin is Still Efficacious in Heavily Pretreated Patients with Steroid-Resistant Gastrointestinal Graft-versus-Host Disease
|
Giannoni, Livia |
|
|
26 |
9 |
p. 1620-1626 |
article |
16 |
Improving Oral Health and Modulating the Oral Microbiome to Reduce Bloodstream Infections from Oral Organisms in Pediatric and Young Adult Hematopoietic Stem Cell Transplantation Recipients: A Randomized Controlled Trial
|
Badia, Priscila |
|
|
26 |
9 |
p. 1704-1710 |
article |
17 |
Incidence, Risk Factors, and Outcomes of Chronic Graft-versus-Host Disease in Pediatric Patients with Hematologic Malignancies after T Cell-Replete Myeloablative Haploidentical Hematopoietic Stem Cell Transplantation with Antithymocyte Globulin/Granulocyte Colony-Stimulating Factor
|
Tang, Fei-Fei |
|
|
26 |
9 |
p. 1655-1662 |
article |
18 |
Iron Overload Is Associated with Delayed Engraftment and Increased Nonrelapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell Transplantation
|
Malki, Monzr M. Al |
|
|
26 |
9 |
p. 1697-1703 |
article |
19 |
Ixazomib for Treatment of Refractory Chronic Graft-versus-Host Disease: A Chronic GVHD Consortium Phase II Trial
|
Pidala, Joseph |
|
|
26 |
9 |
p. 1612-1619 |
article |
20 |
Letter to the Editor Regarding “Diagnostic Considerations for COVID-19 in Recipients of Allogeneic Hematopoietic Cell Transplantation”
|
Chhabra, Saurabh |
|
|
26 |
9 |
p. e241-e242 |
article |
21 |
Letter to the Editor Regarding “Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement”
|
Kawedia, Jitesh D. |
|
|
26 |
9 |
p. e232-e234 |
article |
22 |
Male Gonadal Function after Allogeneic Hematopoietic Stem Cell Transplantation in Childhood: A Cross-Sectional, Population-Based Study
|
Mathiesen, Sidsel |
|
|
26 |
9 |
p. 1635-1645 |
article |
23 |
Management of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia: What is the Best Strategy?
|
Kucukyurt, Selin |
|
|
26 |
9 |
p. e237-e238 |
article |
24 |
Masthead (Purpose and Scope)
|
|
|
|
26 |
9 |
p. A10 |
article |
25 |
Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: A Retrospective Cohort Study
|
Paul, Suman |
|
|
26 |
9 |
p. 1679-1688 |
article |
26 |
Officers and Directors of ASTCT
|
|
|
|
26 |
9 |
p. A12 |
article |
27 |
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic/Myeloproliferative Neoplasms-Unclassifiable: A Retrospective Nationwide Study of the Japan Society for Hematopoietic Cell Transplantation
|
Kurosawa, Shuhei |
|
|
26 |
9 |
p. 1607-1611 |
article |
28 |
Recent Advances in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia
|
Bittencourt, Maria C.B. |
|
|
26 |
9 |
p. e215-e221 |
article |
29 |
Reduced Toxicity Conditioning for Nonmalignant Hematopoietic Cell Transplants
|
Contreras, Cristina F. |
|
|
26 |
9 |
p. 1646-1654 |
article |
30 |
Response to Kawedia et al Letter to Editor in Response to the Article by McCune Et Al "Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement"
|
Dupuis, L. Lee |
|
|
26 |
9 |
p. e235-e236 |
article |
31 |
Severity of Cytokine Release Syndrome and Its Association with Infections after T Cell-Replete Haploidentical Related Donor Transplantation
|
Abid, Muhammad Bilal |
|
|
26 |
9 |
p. 1670-1678 |
article |
32 |
Splenomegaly Negatively Impacts Neutrophil Engraftment in Cord Blood Transplantation
|
Yuasa, Mitsuhiro |
|
|
26 |
9 |
p. 1689-1696 |
article |
33 |
Storage, Utilization, and Disposal of Hematopoietic Stem Cell Products in Patients with Multiple Myeloma
|
Krummradt, Felix |
|
|
26 |
9 |
p. 1589-1596 |
article |
34 |
Table of Contents
|
|
|
|
26 |
9 |
p. A13-A18 |
article |
35 |
T Cell Clonal Dynamics Determined by High-Resolution TCR-β Sequencing in Recipients after Allogeneic Hematopoietic Cell Transplantation
|
Leick, Mark |
|
|
26 |
9 |
p. 1567-1574 |
article |
36 |
The Impact of Antibiotic-Mediated Modification of the Intestinal Microbiome on Outcomes of Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-Analysis
|
Gavriilaki, Maria |
|
|
26 |
9 |
p. 1738-1746 |
article |
37 |
The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis
|
Arnold, Staci D. |
|
|
26 |
9 |
p. 1747-1756 |
article |
38 |
The SARS-Cov-2 Pandemic: A Good Time for Stem Cell Transplantation?
|
Dutheil, Frédéric |
|
|
26 |
9 |
p. e239-e240 |
article |
39 |
To Transplant or Not? Weighing the Risks of Blinatumomab Prior to Hematopoietic Stem Cell Transplant in Acute Lymphoblastic Leukemia
|
Grover, Punita |
|
|
26 |
9 |
p. e209-e210 |
article |
40 |
Treatment with Foscarnet after Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Is Associated with Long-Term Loss of Renal Function
|
Foster, Gena G. |
|
|
26 |
9 |
p. 1597-1606 |
article |